BioRem Financial Statements From 2010 to 2025
| BRM Stock | CAD 2.40 0.02 0.83% |
Check BioRem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRem's main balance sheet or income statement drivers, such as , as well as many indicators such as . BioRem financial statements analysis is a perfect complement when working with BioRem Valuation or Volatility modules.
BioRem |
BioRem Inc Company Operating Margin Analysis
BioRem's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current BioRem Operating Margin | 0.07 % |
Most of BioRem's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioRem Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, BioRem Inc has an Operating Margin of 0.0703%. This is 98.7% lower than that of the Machinery sector and 100.34% lower than that of the Industrials industry. The operating margin for all Canada stocks is 101.28% lower than that of the firm.
BioRem Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioRem's current stock value. Our valuation model uses many indicators to compare BioRem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioRem competition to find correlations between indicators driving BioRem's intrinsic value. More Info.BioRem Inc is number one stock in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about 0.24 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for BioRem Inc is roughly 4.08 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioRem's earnings, one of the primary drivers of an investment's value.About BioRem Financial Statements
BioRem investors use historical fundamental indicators, such as BioRem's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioRem. Please read more on our technical analysis and fundamental analysis pages.
BIOREM Inc., an environmental biotechnology company, designs, manufactures, and sells air emissions control systems that are used to eliminate odors, volatile organic compounds , and hazardous air pollutants in Canada, the United States, China, and internationally. In addition, it offers biological processes and testing services media sampling and analysis system review and inspections and media replacements and spare parts. BIOREM INC operates under Pollution Treatment Controls classification in Canada and is traded on TSX Venture Exchange.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioRem Stock Analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.